
AA-115
CAS No. 1818393-16-6
AA-115( AA115 | APG 115 )
Catalog No. M12798 CAS No. 1818393-16-6
AA-115 (APG 115) is a potent and orally active MDM2 inhibitor with Ki <1 nM, potently inhibits SJSA-1 cell growth with IC50 of 60 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 339 | In Stock |
![]() ![]() |
5MG | 560 | In Stock |
![]() ![]() |
10MG | 799 | In Stock |
![]() ![]() |
25MG | 1197 | In Stock |
![]() ![]() |
50MG | 1611 | In Stock |
![]() ![]() |
100MG | 2187 | In Stock |
![]() ![]() |
500MG | 4392 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameAA-115
-
NoteResearch use only, not for human use.
-
Brief DescriptionAA-115 (APG 115) is a potent and orally active MDM2 inhibitor with Ki <1 nM, potently inhibits SJSA-1 cell growth with IC50 of 60 nM.
-
DescriptionAA-115 (APG 115) is a potent and orally active MDM2 inhibitor with Ki <1 nM, potently inhibits SJSA-1 cell growth with IC50 of 60 nM; exhibits IC50 values of 38, 18, and 104 nM in the RS4;11 acute leukemia, LNCaP prostate cancer, and HCT116 colon cancer cell lines, respectively; effectively inhibits tumor growth and causes no or minimal weight loss.
-
In VitroCell Proliferation Assay Cell Line:AGS and MKN45 cells Concentration:0.0001 μM, 0.001 μM, 0.01 μM, 0.1 μM, 1 μM, 10 μM, 100 μMIncubation Time:72 hours Result:Inhibited cell proliferation in a concentration-dependent manner.RT-PCRCell Line:AGS and MKN45 cells Concentration:0.02 μM, 0.2 μM Incubation Time:48 hours Result:Elevated MDM2, p21, PUMA and BAX mRNA expression.Cell Cycle Analysis Cell Line:AGS and MKN45 cells Concentration:0.02 μM, 0.2 μM Incubation Time:48 hoursResult:Arrested cells at G0/G1 phase.Apoptosis Analysis Cell Line:DePTC p53 wide-type cell line: TPC-1 cells, KTC-1 cells .Concentration:0.3μM, 1μM, 3μM, 10 μM Incubation Time:24 hours Result:Reduced cell population in S-phase, whereas accumulation of cells at G2/M phases.Western Blot Analysis Cell Line:AGS and MKN45 cells Concentration:0.2 μM Incubation Time:72 hours Result:Enhanced expressions of MDM2 and p53, stable knockout of p53 abrogated them.
-
In VivoAnimal Model:Four-week-old male BALB/c athymic nude mice with MKN45 cells Dosage:100 mg/kg Administration:Deliverer orally; once daily; 10 days.Result:Decreased xenograft tumor growth.
-
SynonymsAA115 | APG 115
-
PathwayApoptosis
-
TargetMDM2-p53
-
RecptorMDM2-p53
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1818393-16-6
-
Formula Weight642.593
-
Molecular FormulaC34H38Cl2FN3O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (155.62 mM)
-
SMILESO=C1NC2=CC(Cl)=CC=C2[C@]13C4(CCCCC4)N(CC)[C@@H](C(NC5(CC6)CCC6(C(O)=O)CC5)=O)[C@@H]3C7=C(F)C(Cl)=CC=C7
-
Chemical Name4-((3'R,4'S,5'R)-6''-chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2''-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-indoline]-5'-carboxamido)bicyclo[2.2.2]octane-1-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Aguilar A, et al. J Med Chem. 2017 Apr 13;60(7):2819-2839.
molnova catalog



related products
-
p53-MDM2-IN-1
p53-MDM2-IN-1 (Example 30), an inhibitor of the p53-MDM2/X protein interaction, exhibits a K i value of 23.35 μM and holds potential for applications in anti-tumor research.
-
MI 219
MI 219 is a potent, specific MDM2-p53 inhibitor with Ki of 5 nM, >10,000-fold selective for MDM2 over MDMX.
-
p53 17-26
This peptide is amino acids 17 to 26 fragment of p53, the Mdm-2 binding domain of p53 known also as p53N. This sequence contains all of the residues that contact the binding domain of Mdm-2.